Skip Navigation


Occupational Medicine Advance Access originally published online on August 4, 2007
Occupational Medicine 2007 57(8):564-568; doi:10.1093/occmed/kqm079
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
57/8/564    most recent
kqm079v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Price, M. J.
Right arrow Articles by Hodgson, J. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Price, M. J.
Right arrow Articles by Hodgson, J. T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

D. M. McElvenny, Health & Safety Executive. © British Crown Copyright 2007/MOD. Reproduced with the permission of the Controller of Her Britannic Majesty's Stationery Office (UK)

Simian virus 40 and mesothelioma in Great Britain

Malcolm J. Price1, Andrew J. Darnton2, Damien M. McElvenny2 and John T. Hodgson3

1 Department of Social Medicine, University of Bristol, Bristol, BS8 2PR UK
2 Epidemiology Group, Health and Safety Executive, Bootle, L20 7HS, UK
3 Statistics Branch, Health and Safety Executive, Bootle, L20 7HS, UK

Background Simian virus 40 (SV40) is a DNA virus that has been shown capable of infecting and transforming cells in various species. Laboratory studies have suggested that inoculation with SV40 is associated with various types of cancer, including mesothelioma.

Aims To test the hypothesis, via an ecological analysis, that exposure to SV40 via contaminated polio vaccines is a risk factor for mesothelioma in humans.

Methods Mesothelioma mortality rates in Great Britain for two birth cohorts likely to have been exposed to SV40 via poliovirus vaccination were compared with a birth cohort likely to be largely unexposed.

Results There was some evidence for both males (P < 0.05) and females (P < 0.05) that the mesothelioma mortality rates were higher in the first exposed cohort: rate ratio (RR) = 2.4 [95% CI (confidence interval) 1.2–5.0] and RR = 3.7 (95% CI 1.0–14). However, in the second exposed cohort, mortality rates were elevated in females only, and the evidence was slightly less convincing (P = 0.055).

Conclusion Although the results for females show a reduction in the mesothelioma mortality rate coinciding with the introduction of the SV40-free Sabin polio vaccine, the absence of a similar result in males and of a priori biological evidence of a sex-specific SV40 effect, makes chance the most plausible interpretation of these findings.

Keywords      Great Britain; mesothelioma; polio vaccine; simian virus 40


Correspondence to: Andrew J. Darnton, Epidemiology Group, Health and Safety Executive, Bootle, L20 7HS, UK. Tel: +44 151 951 3095; fax: +44 151 951 4703; e-mail: andrew.darnton{at}hse.gsi.gov.uk


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.